# Cochrane Risk of Bias 2 (RoB 2) Assessment

## Study & Result Information
- **Study Citation:** Chen Y, Bian W, Yao Y, et al. Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia for sedation and recovery in lung cancer surgery: A randomized controlled trial. Thoracic Cancer. 2020;11(4):928–934.
- **Source Document in Google Drive:** `Thoracic Cancer - 2020 - Chen - Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia.pdf`
- **Trial Registration:** Chinese Clinical Trial Registry ChiCTR1800016067
- **Population:** 80 lung cancer patients (aged 18–75 years, ASA I–III) undergoing elective thoracoscopic pulmonary lobectomy under general anesthesia.
- **Intervention:** TEAS applied to bilateral Hegu (LI4), Neiguan (PC6), and Zusanli (ST36) starting 30 min before anesthesia induction and continued throughout surgery (dense-disperse 2/100 Hz, current 10–20 mA; n = 40 analyzed).
- **Comparator:** Sham TEAS using identical appearance electrodes applied to same acupoints with 0 mA current delivered (n = 40 analyzed).
- **Assessed Outcome:** Cumulative Postoperative Sufentanil Consumption
- **Assessed Timepoint:** 24 hours postoperatively
- **Numerical Result:**
  - Cumulative sufentanil consumption at 24 hours postoperatively was significantly lower in the TEAS group compared with the Sham group (mean ± SD: 36.4 ± 6.2 µg vs. 49.8 ± 7.8 µg, P < 0.001). Intraoperative propofol requirements and PACU recovery times were also significantly reduced.

---

### Step 1: Study Design Verification
- **Experimental Design:** Prospective, randomized, double-blind, sham-controlled parallel-group trial (1:1 ratio).
- **Unit of Randomization:** Individual patient.

---

### Step 2: Signaling Questions & Domain Evaluations

#### Domain 1: Risk of bias arising from the randomization process
- **1.1 Random sequence generation:** Yes (Y)
  - **Evidence:** "Randomization was generated using a computer-generated random allocation sequence prepared by an independent statistician." (p. 929, col. 2).
- **1.2 Allocation concealment:** Yes (Y)
  - **Evidence:** "The allocation sequence was concealed in sequentially numbered, opaque, sealed envelopes." (p. 929, col. 2).
- **1.3 Baseline balance:** No (N)
  - **Evidence:** Age, sex, BMI, tumor clinical stage, surgical duration, and one-lung ventilation duration were balanced (P > 0.05; Table 1).
- **Domain 1 Judgment:** **Low Risk of Bias**

#### Domain 2: Risk of bias due to deviations from the intended interventions
- **2.1 Participant awareness:** Probably Yes (PY)
  - **Evidence:** Pre-induction stimulation delivered awake; active tingling (10–20 mA) vs. turned-off sham device (0 mA) creates awake sensory contrast.
- **2.2 Carers awareness:** Probably No (PN)
  - **Evidence:** "Thoracic surgeons, intraoperative anesthesiologists, and ward nurses were blinded to group allocation." (p. 930, col. 1).
- **2.3 Contextual deviations:** No (N)
  - **Evidence:** Standardized thoracic anesthesia protocol and PCIA sufentanil rescue analgesia regimen.
- **2.5 Appropriate analysis:** Yes (Y)
  - **Evidence:** 80 randomized (40 TEAS, 40 Sham); all 80 completed and analyzed in assigned groups (100% ITT).
- **Domain 2 Judgment:** **Some concerns Risk of Bias**

#### Domain 3: Risk of bias due to missing outcome data
- **3.1 Data completeness:** Yes (Y)
  - **Evidence:** Complete 24-hour outcome records available for all 80 randomized patients (100% complete data; Fig. 1).
- **Domain 3 Judgment:** **Low Risk of Bias**

#### Domain 4: Risk of bias in measurement of the outcome
- **4.1 Inappropriate measurement:** No (N)
  - **Evidence:** Electronic microprocessor PCIA pump documentation of cumulative sufentanil consumption (µg).
- **4.2 Differ between groups:** No (N)
  - **Evidence:** Identical PCIA programming across all participants.
- **4.3 Assessors aware:** No (N)
  - **Evidence:** "Trained outcome assessors who evaluated postoperative endpoints were blinded to allocation." (p. 930, col. 1).
- **Domain 4 Judgment:** **Low Risk of Bias**

#### Domain 5: Risk of bias in selection of the reported result
- **5.1 Pre-specified analysis plan:** Yes (Y)
  - **Evidence:** Prospectively registered in Chinese Clinical Trial Registry (ChiCTR1800016067) on May 10, 2018.
- **5.2 Result selected:** No (N)
  - **Evidence:** Sufentanil consumption, propofol requirements, and PACU recovery times reported as prespecified.
- **5.3 Multiple analyses:** No (N)
  - **Evidence:** Pre-specified continuous parametric analysis.
- **Domain 5 Judgment:** **Low Risk of Bias**

---

### Step 3: Overall Judgment & Summary Table

| Domain | Judgment | Key Supporting Rationale |
|---|:---:|---|
| **Domain 1: Randomization Process** | **Low** | Computer generation, sealed opaque envelopes, baseline balanced. |
| **Domain 2: Deviations from Intended Interventions** | **Some concerns** | Awake pre-induction sensory contrast between active stimulation and silent 0 mA sham device. |
| **Domain 3: Missing Outcome Data** | **Low** | Zero missing data. |
| **Domain 4: Measurement of the Outcome** | **Low** | Electronic PCIA pump records and blinded outcome assessors. |
| **Domain 5: Selection of the Reported Result** | **Low** | Prospectively registered with complete outcome reporting. |
| **OVERALL RISK OF BIAS** | **SOME CONCERNS** | Some concerns in Domain 2 due to awake pre-induction sensory difference. |

---

### Step 4: Evidence Audit
- Thoracic Cancer - 2020 - Chen...pdf, p. 929, col. 2: "Randomization was generated using a computer-generated random allocation sequence... concealed in sequentially numbered, opaque, sealed envelopes..."
- Thoracic Cancer - 2020 - Chen...pdf, p. 931, Table 2: "Sufentanil consumption at 24 h: TEAS 36.4 ± 6.2 µg vs. Sham 49.8 ± 7.8 µg, P < 0.001."

---

### Step 5: Author Contact Flags
- None.

---

### Step 6: Final Structured Extraction
```json
{
  "study_id": "Chen_2020",
  "source_file": "Thoracic Cancer - 2020 - Chen - Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia.pdf",
  "trial_registration": "ChiCTR1800016067",
  "outcome": "Cumulative sufentanil consumption",
  "timepoint": "24 hours postoperative",
  "sample_size": {
    "teas": 40,
    "sham": 40,
    "total": 80
  },
  "result": {
    "teas_mean": 36.4,
    "teas_sd": 6.2,
    "sham_mean": 49.8,
    "sham_sd": 7.8,
    "p_value": "<0.001"
  },
  "overall_rob": "Some concerns"
}
```
